Choosing a price for a new product, and then justifying that price to payers, is a challenge for all pharmaceutical and biotechnology companies. This challenge becomes even more difficult if you are launching a product during a global economic recession. Watch the webinar now to learn how Valid Insight and a panel of payers and ex-industry representatives discuss the impact of the inevitable future global recession on pricing and market access of pharmaceutical products.

Expert panelists:

  • Anusha Patel, High Cost Medicines and Regional Homecare Lead Pharmacist for the East Midlands; Advisor to NICE and NHS England.
  • Bertrand Tardivel Former Head of Global Pricing at Takeda; founder of Frehel.
  • Jaime Espin Former Member of the WHO Guideline Panel on Country Pharmaceutical Pricing Policies, and pricing advisor to the European Commission.


    By submitting this information, you agree to the Valid Insight Privacy Policy.